Cytalux FDA Agree To New Imaging Medicine To Assist Recognize Ovarian Cancer Lesions 3 years ago The U.S. Food and Drug Administration today endorsed Cytalux (pafolacianine), an imaging drug expected to help specialists in distinguishing ovarian…